Home/Filings/4/0001847903-24-000031
4//SEC Filing

Rotman Harris 4

Accession 0001847903-24-000031

CIK 0001847903other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:03 PM ET

Size

11.4 KB

Accession

0001847903-24-000031

Insider Transaction Report

Form 4
Period: 2024-02-01
Rotman Harris
SVP Regulatory Affairs
Transactions
  • Tax Payment

    Ordinary Shares

    2024-02-01$8.19/sh4,108$33,64566,892 total
  • Award

    Ordinary Shares

    2024-02-01+37,50071,000 total
  • Sale

    Ordinary Shares

    2024-02-01$8.10/sh4,267$34,57462,625 total
  • Award

    Share Option (right to buy)

    2024-02-01+75,00075,000 total
    Exercise: $8.01Exp: 2034-02-01Ordinary Shares (75,000 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2025.
  • [F3]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
  • [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2023.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.83 to $8.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F6]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001981420

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:03 PM ET
Size
11.4 KB